2019

1. FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis

   Journal of Clinical Pharmacology, Vol. 59, Núm. 4, pp. 517-531